Decreased butyrylcholinesterase and oxytocin levels versus increased dopamine levels in advanced Alzheimer’s patients. Ann Med Res . 2022;29(8):864-868. Accessed April 4, 2025. http://annalsmedres.org/index.php/aomr/article/view/4240